Combined effect of epigallocatechin gallate and triclosan on enoyl-ACP reductase of Mycobacterium tuberculosis

Biochemical and Biophysical Research Communications

Volumn 368, Issue 1, 2008, Pages 12-17

  Sharma, Shailendra Kumar ^a   Kumar, Gyanendra ^a   Kapoor, Mili ^a   Surolia, Avadhesha ^a,b  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

Author keywords

EGCG; Enoyl reductase; Epigallocatechin gallate; FAS I; FAS II; Fluorescence titration; InhA; Mycobacterium tuberculosis; Scatchard plot; Tea catechins; Triclosan; Tuberculosis

Indexed keywords

CATECHIN; ENOYL ACYL CARRIER PROTEIN REDUCTASE (NADH); EPIGALLOCATECHIN GALLATE; TRICLOSAN;

ARTICLE; BACTERIAL GENE; BINDING ASSAY; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME BINDING; ENZYME INHIBITION; FLUORESCENCE; IC 50; INHA GENE; MOLECULAR MODEL; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SCATCHARD PLOT; SPECTROPHOTOMETRY; TEA; TITRIMETRY;

CATECHIN; ENOYL-(ACYL-CARRIER-PROTEIN) REDUCTASE (NADH); ENZYME INHIBITORS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; MYCOBACTERIUM TUBERCULOSIS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SPECTROMETRY, FLUORESCENCE; TRICLOSAN;

MYCOBACTERIUM TUBERCULOSIS;

EID: 39149099113     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.10.191     Document Type: Article

References (27)

1. World Health Organization, Fact sheet on tuberculosis, 2005, .
2. Schroeder E.K., de Souza N., Santos D.S., Blanchard J.S., and Basso L.A. Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis. Curr. Pharm. Biotechnol. 3 3 (2002) 197-225
3. Bhatt A., Molle V., Besra G.S., Jacobs Jr. W.R., and Kremer L. The Mycobacterium tuberculosis FAS-II condensing enzymes: their role in mycolic acid biosynthesis, acid-fastness, pathogenesis and in future drug development. Mol. Microbiol. 64 6 (2007) 1442-1454
4. Smith S., Witkowski A., and Joshi A.K. Structural and functional organization of the animal fatty acid synthase. Prog. Lipid Res. 42 (2003) 289-317
5. Rock C.O., and Cronan J.E. Escherichia coli as a model for the regulation of dissociable (type II) fatty acid biosynthesis. Biochim. Biophys. Acta 1302 (1996) 1-16
6. Surolia N., and Surolia A. Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum. Nat. Med. 7 2 (2001) 167-173
7. Payne D.J. The potential of bacterial fatty acid biosynthetic enzymes as a source of novel antibacterial agents. Drug News Perspect. 17 3 (2004) 187-194
8. Zhang Y.M., Lu Y.J., and Rock C.O. The reductase steps of the type II fatty acid synthase as antimicrobial targets. Lipids 39 (2004) 1055-1060
9. Oliveira J.S., Vasconcelos I.B., Moreira I.S., Santos D.S., and Basso L.A. Enoyl reductases as targets for the development of anti-tubercular and anti-malarial agents. Curr. Drug Targets 8 3 (2007) 399-411
10. Banerjee A., Dubnau E., Quemard A., Balasubramanian V., Um K.S., Wilson T., Collins D., de Lisle G., and Jacobs Jr. W.R. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263 5144 (1994) 227-230
11. Zhang Y.M., and Rock C.O. Evaluation of epigallocatechin gallate and related plant polyphenols as inhibitors of the FabG and FabI reductases of bacterial type II fatty-acid synthase. J. Biol. Chem. 279 (2004) 30994-31001
12. Sharma S.K., Parasuraman P., Kumar G., Surolia N., and Surolia A. Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR). J. Med. Chem. 50 4 (2007) 765-775
13. Slayden R.A., Lee R.E., and Barry III C.E. Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis. Mol. Microbiol. 38 3 (2000) 514-525
14. Parikh S.L., Xiao G., and Tonge P.J. Inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis, by triclosan and isoniazid. Biochemistry 39 26 (2000) 7645-7650
15. Kapoor M., Reddy C.C., Krishnasastry M.V., Surolia N., and Surolia A. Slow-tight-binding inhibition of enoyl-acyl carrier protein reductase from Plasmodium falciparum by triclosan. Biochem. J. 381 (2004) 719-724
16. Taylor N. Green Tea. The Natural Secret for a Healthier Life (1998), Kensington Publishing Corp., New York, NY
17. Cooper R., Morré D.J., and Morré D.M. Medicinal benefits of green tea: part II. Review of anticancer properties. J. Alternat. Complement. Med. 11 (2005) 639-652
18. Anand P.K., Kaul D., and Sharma M. Green tea polyphenol inhibits Mycobacterium tuberculosis survival within human macrophages. Int. J. Biochem. Cell. Biol. 38 4 (2006) 600-609
19. Parikh S., Moynihan D.P., Xiao G., and Tonge P.J. Roles of tyrosine 158 and lysine 165 in the catalytic mechanism of InhA, the Enoyl-ACP reductase from Mycobacterium tuberculosis. Biochemistry 38 (1999) 13623-13634
20. Scatchard G. The attraction of proteins for small molecules and ions. Ann. N.Y. Acad. Sci. 51 (1949) 660
21. Houtzager V., Oullet M., Flagueyret J.-P., Passmore I.A., Bayly C., and Percival M.D. Inhibitor-induced changes in the intrinsic fluorescence of human cyclooxygenase-2. Biochemistry 35 (1996) 10974-10984
22. Lakowicz J.R. Principles of Fluorescence Spectroscopy (1983), Plenum Press, New York
23. Morris G.M., Goodsell D.S., Halliday R.S., Huey R., Hart W.E., Belew R.K., and Olson A.J. Automated docking using a Lamarckian genetic algorithm and empirical binding free energy function, J. Comp. Chem. 19 (1998) 1639-1662
24. Molecular Operating Environment [MOE 2001.07], Chemical Computing Group Inc., 1255 University St., Suite 1600, Montreal, Que., Canada H3B 3X3.
25. He X., Alian A., Stroud R., and Ortiz de Montellano P.R. Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis. J. Med. Chem. 49 21 (2006) 6308-6323
26. Tonge P.J., Kisker C., and Slayden R.A. Development of modern InhA inhibitors to combat drug resistant strains of Mycobacterium tuberculosis. Curr. Top. Med. Chem. 7 5 (2007) 489-498
27. Pidugu L.S., Kapoor M., Surolia N., Surolia A., and Suguna K. Structural basis for the variation in triclosan affinity to enoyl reductases. J. Mol. Biol. 343 1 (2004) 147-155